-
1
-
-
0041466261
-
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
-
Green AR, mechan AO, Elliott JM, O'shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55:463-508.
-
(2003)
Pharmacol Rev
, vol.55
, pp. 463-508
-
-
Green, A.R.1
mechan, A.O.2
Elliott, J.M.3
O'shea, E.4
Colado, M.I.5
-
2
-
-
34548331211
-
Um estudo sobre a psicodinâmica do usuário de ecstasy
-
Sardinha LS, Garcia AL. Um estudo sobre a psicodinâmica do usuário de ecstasy. Psicologia: teoria e prática. 2000;2(2):70-87.
-
(2000)
Psicologia: Teoria e prática
, vol.2
, Issue.2
, pp. 70-87
-
-
Sardinha, L.S.1
Garcia, A.L.2
-
3
-
-
12344323600
-
Ecstasy: Pharmacology and neurotoxicity
-
Morton J. Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol. 2005;5:79-86.
-
(2005)
Curr Opin Pharmacol
, vol.5
, pp. 79-86
-
-
Morton, J.1
-
6
-
-
0035664224
-
-
Canadian medical Association or its licensors
-
Kalante H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. Canadian medical Association or its licensors. 2001;165(7):917-28.
-
(2001)
The pharmacology and toxicology of ecstasy
, vol.165
, Issue.7
, pp. 917-928
-
-
Kalante, H.1
-
7
-
-
24344506132
-
Mental disorders in current and former heavy ecstasy (MDMA) users
-
Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A. Mental disorders in current and former heavy ecstasy (MDMA) users. Addiction. 2005;100(9):1310-19.
-
(2005)
Addiction
, vol.100
, Issue.9
, pp. 1310-1319
-
-
Thomasius, R.1
Petersen, K.U.2
Zapletalova, P.3
Wartberg, L.4
Zeichner, D.5
Schmoldt, A.6
-
8
-
-
33846830016
-
Who is becoming hallucinogen dependent soon after hallucinogen use starts?
-
Stone AL, O'Brien MS, De la Torre A, Anthony JC. Who is becoming hallucinogen dependent soon after hallucinogen use starts? Drug Alcohol Depend. 2007;87(2/3):153-63.
-
(2007)
Drug Alcohol Depend
, vol.87
, Issue.2-3
, pp. 153-163
-
-
Stone, A.L.1
O'Brien, M.S.2
De la Torre, A.3
Anthony, J.C.4
-
9
-
-
33745214215
-
Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia
-
White B, Day C, Degenhardt L, Kinner S, Fry C, Bruno R, et al. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. Drug Alcohol Depend. 2006;83(3):210-7.
-
(2006)
Drug Alcohol Depend
, vol.83
, Issue.3
, pp. 210-217
-
-
White, B.1
Day, C.2
Degenhardt, L.3
Kinner, S.4
Fry, C.5
Bruno, R.6
-
10
-
-
25144472627
-
Comparative study of drug use among undergraduate students at the University of Sao Paulo - Sao Paulo campus in 1996 and 2001
-
Stempliuk VA, Barroso LP, Andrade AG, Nicastri S, Malbergier A. Comparative study of drug use among undergraduate students at the University of Sao Paulo - Sao Paulo campus in 1996 and 2001. Rev Bras Psiquiatr. 2005;27(3):185-93.
-
(2005)
Rev Bras Psiquiatr
, vol.27
, Issue.3
, pp. 185-193
-
-
Stempliuk, V.A.1
Barroso, L.P.2
Andrade, A.G.3
Nicastri, S.4
Malbergier, A.5
-
11
-
-
4243586451
-
Polícia fecha laboratório de ecstasy em São Paulo
-
Sec. C1
-
Silva A. Polícia fecha laboratório de ecstasy em São Paulo. Folha de São Paulo. 2000, Sec. C1.
-
(2000)
Folha de São Paulo
-
-
Silva, A.1
-
12
-
-
19544391657
-
O uso de êxtase (MDMA) na cidade de São Paulo e imediações: Um estudo etnográfico.
-
Baptista MC, Noto AR, Carlini EA. O uso de êxtase (MDMA) na cidade de São Paulo e imediações: Um estudo etnográfico. J Bras Psiquiatria. 2002;51:81-9.
-
(2002)
J Bras Psiquiatria
, vol.51
, pp. 81-89
-
-
Baptista, M.C.1
Noto, A.R.2
Carlini, E.A.3
-
13
-
-
0037353136
-
Ecstasy (MDMA): Effects and patterns of use reported by users in Sao Paulo
-
Almeida SP, Silva MTA. Ecstasy (MDMA): effects and patterns of use reported by users in Sao Paulo. Rev Bras Psiquiatria. 2003;25(1):11-7.
-
(2003)
Rev Bras Psiquiatria
, vol.25
, Issue.1
, pp. 11-17
-
-
Almeida, S.P.1
Silva, M.T.A.2
-
14
-
-
0031253720
-
MDMA (ecstasy) and the rave: A review
-
Schwartz RH, Miller NS. MDMA (ecstasy) and the rave: a review. Pediatrics. 1997;100(4):705-8.
-
(1997)
Pediatrics
, vol.100
, Issue.4
, pp. 705-708
-
-
Schwartz, R.H.1
Miller, N.S.2
-
15
-
-
0028292728
-
3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Pharmacology and toxicology in animals and humans
-
Steele TD, Mccann UD, Ricaurte GA. 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): pharmacology and toxicology in animals and humans. Addiction. 1994;89:539-51.
-
(1994)
Addiction
, vol.89
, pp. 539-551
-
-
Steele, T.D.1
Mccann, U.D.2
Ricaurte, G.A.3
-
16
-
-
0029828010
-
-
Laranjeiras R, Dunn J, Rassi R, Fernandes M. Êxtase (3,4-metilenodioximetanfetamina, MDMA): uma droga velha e um problema novo? ABP-APAL. 1996;18(3):77-81.
-
(1996)
Êxtase (3,4-metilenodioximetanfetamina, MDMA): Uma droga velha e um problema novo? ABP-APAL
, vol.18
, Issue.3
, pp. 77-81
-
-
Laranjeiras, R.1
Dunn, J.2
Rassi, R.3
Fernandes, M.4
-
17
-
-
0033967676
-
Non-linear pharmacokinetics of MDMA ("ecstasy") in humans
-
De la Torre R, Farré M, Mas M, Segura J, Camí J. Non-linear pharmacokinetics of MDMA ("ecstasy") in humans. Br J Clin Pharmacol. 2000;49:104-9.
-
(2000)
Br J Clin Pharmacol
, vol.49
, pp. 104-109
-
-
De la Torre, R.1
Farré, M.2
Mas, M.3
Segura, J.4
Camí, J.5
-
18
-
-
47749112196
-
-
Mascaró BI, Aznar BA, Serrano GJ, Lopez-Briz E, Martini-Bonmati E. MDMA Extasis: Revisión y puesta al día. Rev Esp Drogodep. 1991;16(2):91-101.
-
Mascaró BI, Aznar BA, Serrano GJ, Lopez-Briz E, Martini-Bonmati E. MDMA "Extasis": Revisión y puesta al día. Rev Esp Drogodep. 1991;16(2):91-101.
-
-
-
-
19
-
-
84983085465
-
Ecstasy intoxication: The toxicological basis for treatment
-
Ferigolo M, Machado AGS, Oliveira NB, Barros HMT. Ecstasy intoxication: the toxicological basis for treatment. Rev Hosp Clin Fac med S Paulo. 2003;56(6):332-41.
-
(2003)
Rev Hosp Clin Fac med S Paulo
, vol.56
, Issue.6
, pp. 332-341
-
-
Ferigolo, M.1
Machado, A.G.S.2
Oliveira, N.B.3
Barros, H.M.T.4
-
20
-
-
2542629618
-
Bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities
-
Schifano FA. Bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacol. 2004;173:242-8.
-
(2004)
Psychopharmacol
, vol.173
, pp. 242-248
-
-
Schifano, F.A.1
-
21
-
-
0034092057
-
Identification of the human cytochromes P450 involved in the oxidative metabolism of Ecstasy related designer grugs
-
Kreth K, Kovar K, Schwab M, Zanger UM. Identification of the human cytochromes P450 involved in the oxidative metabolism of Ecstasy related designer grugs. Biochem Pharmacol. 2000;59:1563 -71.
-
(2000)
Biochem Pharmacol
, vol.59
, pp. 1563-1571
-
-
Kreth, K.1
Kovar, K.2
Schwab, M.3
Zanger, U.M.4
-
23
-
-
0037096036
-
Reduced 3,4-methylenedioxymethamphetamine (ecstasy) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro
-
Ramamoorthy Y, Yu Am, Suh N, Haining RL, Tyndale RF, Sellers EM. Reduced 3,4-methylenedioxymethamphetamine (ecstasy) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro. Biochem Pharmacol. 2002;3:2111-9.
-
(2002)
Biochem Pharmacol
, vol.3
, pp. 2111-2119
-
-
Ramamoorthy, Y.1
Yu, A.2
Suh, N.3
Haining, R.L.4
Tyndale, R.F.5
Sellers, E.M.6
-
24
-
-
0032576351
-
Fatal interaction between ritonavir and MDMA
-
Henry J, Hill IR. Fatal interaction between ritonavir and MDMA. Lancet. 1998;28:1751-2.
-
(1998)
Lancet
, vol.28
, pp. 1751-1752
-
-
Henry, J.1
Hill, I.R.2
-
25
-
-
0033778086
-
Ecstasy (MDMA): A review of its possible persistent psychological effects
-
Morgan MJ. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacol. 2000;152:230-48.
-
(2000)
Psychopharmacol
, vol.152
, pp. 230-248
-
-
Morgan, M.J.1
-
26
-
-
0026716102
-
Phenomenology and sequelae of 3,4-methylenedimethoxymethamphetamine use
-
Liester M, Grob C, Bravo G. Phenomenology and sequelae of 3,4-methylenedimethoxymethamphetamine use. J Nerv ment Dis. 1992;180:345-52.
-
(1992)
J Nerv ment Dis
, vol.180
, pp. 345-352
-
-
Liester, M.1
Grob, C.2
Bravo, G.3
-
27
-
-
0022834268
-
MDMA nonmedical use and intoxication
-
Siegel RK. MDMA nonmedical use and intoxication. J Psychoactive Drugs. 1986;18(4):349-54.
-
(1986)
J Psychoactive Drugs
, vol.18
, Issue.4
, pp. 349-354
-
-
Siegel, R.K.1
-
28
-
-
0033660972
-
Acute psychosis with agressive behavior as a consequence of MDMA (ecstasy) consumption
-
Milas M. Acute psychosis with agressive behavior as a consequence of MDMA (ecstasy) consumption. Lijec Vjesn. 2000;122(1-2):27-30.
-
(2000)
Lijec Vjesn
, vol.122
, Issue.1-2
, pp. 27-30
-
-
Milas, M.1
-
29
-
-
0025863667
-
Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine ("ecstasy") in recreational users
-
Mccann U, Ricaurte G. Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine ("ecstasy") in recreational users. J Clin Psychopharmacol. 1991;11:302-5.
-
(1991)
J Clin Psychopharmacol
, vol.11
, pp. 302-305
-
-
Mccann, U.1
Ricaurte, G.2
-
30
-
-
0026073632
-
Chronic paranoid psychosis after misure of MDMA ("ecstasy")
-
Mcguire P, Fahy T. Chronic paranoid psychosis after misure of MDMA ("ecstasy"). BMJ. 1991;302:697.
-
(1991)
BMJ
, vol.302
, pp. 697
-
-
Mcguire, P.1
Fahy, T.2
-
31
-
-
0033921470
-
Potential human neurotoxicity of MDMA ("ecstasy"): Subjective self-reports, evidence from an Italian drug addicition centre and clinical case studies
-
Schifano F. Potential human neurotoxicity of MDMA ("ecstasy"): subjective self-reports, evidence from an Italian drug addicition centre and clinical case studies. Neuropsychobiol. 2000;42(1):25-33.
-
(2000)
Neuropsychobiol
, vol.42
, Issue.1
, pp. 25-33
-
-
Schifano, F.1
-
32
-
-
0029846728
-
Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy")
-
Mccann UD, Slate SO, Ricaurte GA. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"). Drug Safety. 1996;15:107-15.
-
(1996)
Drug Safety
, vol.15
, pp. 107-115
-
-
Mccann, U.D.1
Slate, S.O.2
Ricaurte, G.A.3
-
33
-
-
0027973302
-
Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ("ecstasy")
-
Marsh JC, Abboudi ZH, Gibson FM, Scoopes J, Daly S, O'Shaunnessy DF, et al. Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ("ecstasy"). Br J Haematol. 1994;88:281-5.
-
(1994)
Br J Haematol
, vol.88
, pp. 281-285
-
-
Marsh, J.C.1
Abboudi, Z.H.2
Gibson, F.M.3
Scoopes, J.4
Daly, S.5
O'Shaunnessy, D.F.6
-
34
-
-
47749115847
-
Revisão toxicológica e tratamento da intoxicaçã o pelo êxtase.
-
Souza LMV, Hoshi L, Lima LF, Santiago MM, Alves MPR, Mendonça LO, et al. Revisão toxicológica e tratamento da intoxicaçã o pelo êxtase. Rev Neurociências. 2003;11(1):18-22.
-
(2003)
Rev Neurociências
, vol.11
, Issue.1
, pp. 18-22
-
-
Souza, L.M.V.1
Hoshi, L.2
Lima, L.F.3
Santiago, M.M.4
Alves, M.P.R.5
Mendonça, L.O.6
-
35
-
-
0029067178
-
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy")
-
Green AR, Cross AJ, Goodwin GM. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacol. 1996;119:247-60.
-
(1996)
Psychopharmacol
, vol.119
, pp. 247-260
-
-
Green, A.R.1
Cross, A.J.2
Goodwin, G.M.3
-
36
-
-
4143152622
-
Human pharmacology of MDMA: Pharmacokinetics, metabolism and disposition
-
De la Torre R, Farre M, Roset PN, et al. Human pharmacology of MDMA: pharmacokinetics, metabolism and disposition. Ther Drug Monit. 2004;26:137-44.
-
(2004)
Ther Drug Monit
, vol.26
, pp. 137-144
-
-
De la Torre, R.1
Farre, M.2
Roset, P.N.3
-
37
-
-
0027278178
-
Effects of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity
-
Brodkin J, Malyala A, Nash JF. Effects of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav. 1993;45:647-53.
-
(1993)
Pharmacol Biochem Behav
, vol.45
, pp. 647-653
-
-
Brodkin, J.1
Malyala, A.2
Nash, J.F.3
-
38
-
-
0028104042
-
MDMA (ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac)
-
Leonardi ET, Azmitia EC. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacol. 1994;10:231-8.
-
(1994)
Neuropsychopharmacol
, vol.10
, pp. 231-238
-
-
Leonardi, E.T.1
Azmitia, E.C.2
-
39
-
-
4243561090
-
Evidence against MDMA-induced hyperthermia being mediated by 5-HT release in the brain
-
Mechan AO, Colado MI, Esteban B, Elliott JM, Green AR. Evidence against MDMA-induced hyperthermia being mediated by 5-HT release in the brain. Br J Pharmacol. 2000;131:153.
-
(2000)
Br J Pharmacol
, vol.131
, pp. 153
-
-
Mechan, A.O.1
Colado, M.I.2
Esteban, B.3
Elliott, J.M.4
Green, A.R.5
-
40
-
-
0023735752
-
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity
-
O'Hearn E, Battaglia G, Souza EB, Kuhar MJ, Molliver ME. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci. 1988;8:2788-803.
-
(1988)
J Neurosci
, vol.8
, pp. 2788-2803
-
-
O'Hearn, E.1
Battaglia, G.2
Souza, E.B.3
Kuhar, M.J.4
Molliver, M.E.5
-
41
-
-
0023475168
-
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine
-
Schmidt CJ, Taylor VL. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol. 1987;36:4095-5102.
-
(1987)
Biochem Pharmacol
, vol.36
, pp. 4095-5102
-
-
Schmidt, C.J.1
Taylor, V.L.2
-
42
-
-
0026296836
-
Ecstasy: Towards an understanding of the biochemical basis of the actions of MDMA
-
Rattray M. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem. 1991;26:77-87.
-
(1991)
Essays Biochem
, vol.26
, pp. 77-87
-
-
Rattray, M.1
-
43
-
-
0030660459
-
Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners
-
Huether G, Zhou D, Ruther E. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. J Neural Transm (Budapest). 1997;104(8-9):771-94.
-
(1997)
J Neural Transm (Budapest)
, vol.104
, Issue.8-9
, pp. 771-794
-
-
Huether, G.1
Zhou, D.2
Ruther, E.3
-
44
-
-
0035989471
-
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, ephinephrine and dopamine in ecstasy users
-
Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, Thomasius R. Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, ephinephrine and dopamine in ecstasy users. Neuro Endocrinol Lett. 2002;23:259-61.
-
(2002)
Neuro Endocrinol Lett
, vol.23
, pp. 259-261
-
-
Stuerenburg, H.J.1
Petersen, K.2
Baumer, T.3
Rosenkranz, M.4
Buhmann, C.5
Thomasius, R.6
-
45
-
-
30644457692
-
Role of alpha 2A-adrenoceptors in the effects of MDMA on body temperature in the mouse
-
Bexis S, Docherty JR. Role of alpha 2A-adrenoceptors in the effects of MDMA on body temperature in the mouse. Br J Pharmacol. 2005;145:1-6.
-
(2005)
Br J Pharmacol
, vol.145
, pp. 1-6
-
-
Bexis, S.1
Docherty, J.R.2
-
46
-
-
0032585937
-
Investigation of the prejunctional α2 adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
-
Lavelle A, Honner V, Docherty JR. Investigation of the prejunctional α2 adrenoceptor mediated actions of MDMA in rat atrium and vas deferens. Br J Pharmacol. 1999;128:975-80.
-
(1999)
Br J Pharmacol
, vol.128
, pp. 975-980
-
-
Lavelle, A.1
Honner, V.2
Docherty, J.R.3
-
47
-
-
0034762682
-
Vascular actions of MDMA involve α1 and α2 adrenoceptors in the anaesthetized rat
-
McDaid J, Docherty JR. Vascular actions of MDMA involve α1 and α2 adrenoceptors in the anaesthetized rat. Br J Pharmacol. 2001;133:429-37.
-
(2001)
Br J Pharmacol
, vol.133
, pp. 429-437
-
-
McDaid, J.1
Docherty, J.R.2
-
48
-
-
0034090539
-
MDMA ("ecstasy") enhances basal acetylcholine release in brain slices of the rat striatum
-
Fischer HS, Zerning G, Schatz DS, Humpel C, Saria A. MDMA ("ecstasy") enhances basal acetylcholine release in brain slices of the rat striatum. Eur J Neurosci. 2000;12(4):1385-90.
-
(2000)
Eur J Neurosci
, vol.12
, Issue.4
, pp. 1385-1390
-
-
Fischer, H.S.1
Zerning, G.2
Schatz, D.S.3
Humpel, C.4
Saria, A.5
-
49
-
-
0034690772
-
MDMA (Ecstasy) neurotoxicity: Assessing and communicating the risks
-
Boot BP, McGregor IS, Hall W. MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet. 2000;355:1818-21.
-
(2000)
Lancet
, vol.355
, pp. 1818-1821
-
-
Boot, B.P.1
McGregor, I.S.2
Hall, W.3
-
50
-
-
0032985047
-
Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users
-
Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users. Br J Psychiatry. 1999;175:63-9.
-
(1999)
Br J Psychiatry
, vol.175
, pp. 63-69
-
-
Semple, D.M.1
Ebmeier, K.P.2
Glabus, M.F.3
O'Carroll, R.E.4
Johnstone, E.C.5
-
51
-
-
0036181729
-
The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT 2A receptors in rat and human brain
-
Renemen L, Endert E, De Bruin K, Lavalaye J, Feenstra MG, De Wolff FA, et al. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT 2A receptors in rat and human brain. Neuropsychopharmacol. 2002;26:387-96.
-
(2002)
Neuropsychopharmacol
, vol.26
, pp. 387-396
-
-
Renemen, L.1
Endert, E.2
De Bruin, K.3
Lavalaye, J.4
Feenstra, M.G.5
De Wolff, F.A.6
-
52
-
-
0036123041
-
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
-
Kish SJ. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav. 2002;71:845-55.
-
(2002)
Pharmacol Biochem Behav
, vol.71
, pp. 845-855
-
-
Kish, S.J.1
-
53
-
-
0030986255
-
In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (ecstasy) and p-chloroamphetamine but not the degeneration following fenfluramine
-
Colado MI, O'Shea E, Granados R, Murray TK, Green AR. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (ecstasy) and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol. 1997;21:889-900.
-
(1997)
Br J Pharmacol
, vol.21
, pp. 889-900
-
-
Colado, M.I.1
O'Shea, E.2
Granados, R.3
Murray, T.K.4
Green, A.R.5
-
54
-
-
0032763755
-
Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine
-
Shankaran M, Yamamoto BK, Gudelsky GA. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur J Pharmacol. 1999;385:103-10.
-
(1999)
Eur J Pharmacol
, vol.385
, pp. 103-110
-
-
Shankaran, M.1
Yamamoto, B.K.2
Gudelsky, G.A.3
-
55
-
-
0029078456
-
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits
-
Sprague JE, Nichols DE. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J Pharmacol Exp Ther. 1995;273:667-73.
-
(1995)
J Pharmacol Exp Ther
, vol.273
, pp. 667-673
-
-
Sprague, J.E.1
Nichols, D.E.2
-
56
-
-
0035123882
-
Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT
-
Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse. 2001;40:55-64.
-
(2001)
Synapse
, vol.40
, pp. 55-64
-
-
Shankaran, M.1
Yamamoto, B.K.2
Gudelsky, G.A.3
-
57
-
-
0031847891
-
Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice
-
Ali SF, Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann NY Acad Sci. 1998;844:122-30.
-
(1998)
Ann NY Acad Sci
, vol.844
, pp. 122-130
-
-
Ali, S.F.1
Itzhak, Y.2
-
58
-
-
0035679302
-
A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on dopamine neurons in mouse brain
-
Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM et al. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on dopamine neurons in mouse brain. Br J Pharmacol. 2001;134:1711-23.
-
(2001)
Br J Pharmacol
, vol.134
, pp. 1711-1723
-
-
Colado, M.I.1
Camarero, J.2
Mechan, A.O.3
Sanchez, V.4
Esteban, B.5
Elliott, J.M.6
-
59
-
-
0029002294
-
Involvement of oxidative and L-arginine NO pathways in the neurotoxicity of drugs of abuse in vitro
-
Cerruti C, Sheng P, Ladenheim B, Esptien CJ, Cadet JL. Involvement of oxidative and L-arginine NO pathways in the neurotoxicity of drugs of abuse in vitro. Clin Exp Pharmacol Physiol. 1995;22:381-2.
-
(1995)
Clin Exp Pharmacol Physiol
, vol.22
, pp. 381-382
-
-
Cerruti, C.1
Sheng, P.2
Ladenheim, B.3
Esptien, C.J.4
Cadet, J.L.5
-
60
-
-
0026466921
-
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: a multicenter report
-
Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:1391-6.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 1391-1396
-
-
Brugada, P.1
Brugada, J.2
-
61
-
-
0036312489
-
Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") ingestion
-
Hartung TK, Schofield E, Short AL, Parr MJA, Henry JA. Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") ingestion. Q J Med. 2002;95:431-7.
-
(2002)
Q J Med
, vol.95
, pp. 431-437
-
-
Hartung, T.K.1
Schofield, E.2
Short, A.L.3
Parr, M.J.A.4
Henry, J.A.5
-
62
-
-
0036131275
-
Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Special toxicology issue
-
Moeller MR, Kraemer T. Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Special toxicology issue. Ther Drug Monitor. 2002; 24(2):210-21.
-
(2002)
Ther Drug Monitor
, vol.24
, Issue.2
, pp. 210-221
-
-
Moeller, M.R.1
Kraemer, T.2
-
64
-
-
0026680529
-
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
-
Henry J, Jeffreys K, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet. 1992;340:384-7.
-
(1992)
Lancet
, vol.340
, pp. 384-387
-
-
Henry, J.1
Jeffreys, K.2
Dawling, S.3
-
65
-
-
0026604823
-
Hyperpyrexia and rhabdomyolysis after MDMA (ecstasy) abuse
-
Screaton GR, Singer M, Cairns HS, Sarner M, Tharsher A, Cohen SL. Hyperpyrexia and rhabdomyolysis after MDMA (ecstasy) abuse. Lancet. 1992;339:677-8.
-
(1992)
Lancet
, vol.339
, pp. 677-678
-
-
Screaton, G.R.1
Singer, M.2
Cairns, H.S.3
Sarner, M.4
Tharsher, A.5
Cohen, S.L.6
-
66
-
-
33646871323
-
Acute toxic effects of "Ecstasy" (MDMA) and related compounds: Overview of pathophysiology and clinical management
-
Hall AP, Henry JA. Acute toxic effects of "Ecstasy" (MDMA) and related compounds: overview of pathophysiology and clinical management. British Journal of Anaesthesia. 2006;96(6):678-85.
-
(2006)
British Journal of Anaesthesia
, vol.96
, Issue.6
, pp. 678-685
-
-
Hall, A.P.1
Henry, J.A.2
-
67
-
-
0029881804
-
Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)
-
Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet. 1996;347:1052.
-
(1996)
Lancet
, vol.347
, pp. 1052
-
-
Holden, R.1
Jackson, M.A.2
-
68
-
-
26444511151
-
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
-
Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434-41.
-
(2005)
Br J Anaesth
, vol.95
, pp. 434-441
-
-
Gillman, P.K.1
-
69
-
-
0035170740
-
Pathophysiological role of the serotonin system in malignant hyperthermia
-
Wappler F, Fiege M, Schulte AM, Esch F. Pathophysiological role of the serotonin system in malignant hyperthermia. Br J Anaesth. 2001;87:794-8.
-
(2001)
Br J Anaesth
, vol.87
, pp. 794-798
-
-
Wappler, F.1
Fiege, M.2
Schulte, A.M.3
Esch, F.4
-
70
-
-
0030040183
-
Pathology of deaths associated with "ecstasy" and "eve" missue
-
Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with "ecstasy" and "eve" missue. J Clin Pathol. 1996;49:149-53.
-
(1996)
J Clin Pathol
, vol.49
, pp. 149-153
-
-
Milroy, C.M.1
Clark, J.C.2
Forrest, A.R.W.3
-
71
-
-
0026684873
-
Ecstasy and the dance of death
-
Henry J. Ecstasy and the dance of death. BMJ. 1992;305:5-6.
-
(1992)
BMJ
, vol.305
, pp. 5-6
-
-
Henry, J.1
-
72
-
-
47749140162
-
-
United Kingdom national Poisons Information Service Guidelines, cited 2007 Sep 3, Available from
-
United Kingdom national Poisons Information Service Guidelines. [cited 2007 Sep 3]. Available from http://www.npis.org
-
-
-
-
73
-
-
47749143775
-
Pharmacologic advances in emergency medicine. New drugs of abuse - 3,4-methylenedioxymethamphetamine
-
Graeme KA. Pharmacologic advances in emergency medicine. New drugs of abuse - 3,4-methylenedioxymethamphetamine. Emergency Medicine Clinics of North America. 2000;18(4).
-
(2000)
Emergency Medicine Clinics of North America
, vol.18
, Issue.4
-
-
Graeme, K.A.1
-
74
-
-
0023819569
-
3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
-
Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, et al. 3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA. 1988;260(1):51-5.
-
(1988)
JAMA
, vol.260
, Issue.1
, pp. 51-55
-
-
Ricaurte, G.A.1
Forno, L.S.2
Wilson, M.A.3
DeLanney, L.E.4
Irwin, I.5
Molliver, M.E.6
|